Next Article in Journal
PPAR-α Deletion Attenuates Cisplatin Nephrotoxicity by Modulating Renal Organic Transporters MATE-1 and OCT-2
Next Article in Special Issue
Epigenetic Regulation of ALS and CMT: A Lesson from Drosophila Models
Previous Article in Journal
A Comparative Transcriptome Analysis, Conserved Regulatory Elements and Associated Transcription Factors Related to Accumulation of Fusariotoxins in Grain of Rye (Secale cereale L.) Hybrids
Previous Article in Special Issue
MicroRNA-31 Regulates Expression of Wntless in Both Drosophila melanogaster and Human Oral Cancer Cells
Open AccessReview

Recent Advances in Drosophila Models of Charcot-Marie-Tooth Disease

1
Department of Molecular Pathobiology of Brain Disease, Kyoto Prefectural University of Medicine, Kyoto 6028566, Japan
2
Department of Neurology, Kyoto Prefectural University of Medicine, Kyoto 6028566, Japan
*
Author to whom correspondence should be addressed.
Int. J. Mol. Sci. 2020, 21(19), 7419; https://doi.org/10.3390/ijms21197419
Received: 31 August 2020 / Revised: 6 October 2020 / Accepted: 6 October 2020 / Published: 8 October 2020
(This article belongs to the Special Issue Role of Drosophila in Human Disease Research 2.0)
Charcot-Marie-Tooth disease (CMT) is one of the most common inherited peripheral neuropathies. CMT patients typically show slowly progressive muscle weakness and sensory loss in a distal dominant pattern in childhood. The diagnosis of CMT is based on clinical symptoms, electrophysiological examinations, and genetic testing. Advances in genetic testing technology have revealed the genetic heterogeneity of CMT; more than 100 genes containing the disease causative mutations have been identified. Because a single genetic alteration in CMT leads to progressive neurodegeneration, studies of CMT patients and their respective models revealed the genotype-phenotype relationships of targeted genes. Conventionally, rodents and cell lines have often been used to study the pathogenesis of CMT. Recently, Drosophila has also attracted attention as a CMT model. In this review, we outline the clinical characteristics of CMT, describe the advantages and disadvantages of using Drosophila in CMT studies, and introduce recent advances in CMT research that successfully applied the use of Drosophila, in areas such as molecules associated with mitochondria, endosomes/lysosomes, transfer RNA, axonal transport, and glucose metabolism. View Full-Text
Keywords: Charcot-Marie-Tooth disease (CMT); Drosophila melanogaster; human disease model; neurodegeneration; peripheral neuropathy Charcot-Marie-Tooth disease (CMT); Drosophila melanogaster; human disease model; neurodegeneration; peripheral neuropathy
Show Figures

Figure 1

MDPI and ACS Style

Kitani-Morii, F.; Noto, Y.-i. Recent Advances in Drosophila Models of Charcot-Marie-Tooth Disease. Int. J. Mol. Sci. 2020, 21, 7419.

AMA Style

Kitani-Morii F, Noto Y-i. Recent Advances in Drosophila Models of Charcot-Marie-Tooth Disease. International Journal of Molecular Sciences. 2020; 21(19):7419.

Chicago/Turabian Style

Kitani-Morii, Fukiko; Noto, Yu-ichi. 2020. "Recent Advances in Drosophila Models of Charcot-Marie-Tooth Disease" Int. J. Mol. Sci. 21, no. 19: 7419.

Find Other Styles
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Article Access Map by Country/Region

1
Search more from Scilit
 
Search
Back to TopTop